• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腮腺导管剂量对头颈部鳞状细胞癌放疗后粘性唾液和口干的影响。

Effect of dose to parotid ducts on Sticky Saliva and Xerostomia in radiotherapy of head and neck squamous cell carcinoma.

机构信息

Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Freiburgstrasse 18, Bern, CH-3010, Switzerland.

Graduate School for Health Sciences, University of Bern, Bern, Switzerland.

出版信息

Radiat Oncol. 2024 Aug 2;19(1):104. doi: 10.1186/s13014-024-02495-6.

DOI:10.1186/s13014-024-02495-6
PMID:39095864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11295643/
Abstract

BACKGROUND

Radiotherapy (RT) in head and neck squamous cell cancer (HNSCC) often leads to sticky saliva and xerostomia (SSX). Dose sparing of salivary glands (SG) reduces occurrence of SSX but few studies investigated the relationship between RT dose to SG substructures and SSX. We therefore investigated this hypothesis, focusing on the parotid duct (PD).

METHODS

Retrospective data was collected from 99 HNSCC patients treated at our center with (chemo-)radiotherapy (CRT). PD and other organs-at-risk (OAR) were (re-)contoured and DVHs were generated without re-planning. SSX was graded according to CTCAE v.4.03 and evaluated at acute, subacute, and two late timepoints.

RESULTS

Most patients presented with loco-regionally advanced disease. In 47% of patients, up-front neck dissection preceded CRT. Weighted mean dose was 28.6 Gy for bilateral parotid glands (PG), and 32.0 Gy for PD. Acute SSX presented as grades 0 (35.3%), I (41.4%), II (21.2%) and III (2.0%). There was no association of OARs and SSX ≥ grade 2 in univariable logistic regression (LR). Multivariable LR showed statistically significant relationship of acute SSX with: PG weighted mean dose (OR 0.84, p = 0.004), contralateral PG mean dose (OR 1.14, p = 0.02) and contralateral PD planning OAR (PD PRV) mean dose (OR 1.84, p = 0.03).

CONCLUSIONS

There was an association of acute SSX with dose exposure of PD PRV in multivariable regression, only. Due to statistical uncertainties and the retrospective nature of this analysis, further studies are required to confirm or reject the hypothesis.

摘要

背景

头颈部鳞状细胞癌(HNSCC)的放射治疗(RT)常导致唾液粘稠和口干(SSX)。唾液腺(SG)剂量节省可减少 SSX 的发生,但很少有研究调查 SG 亚结构与 SSX 之间的关系。因此,我们提出了这一假设,重点研究腮腺导管(PD)。

方法

从我院接受(放)化疗(CRT)治疗的 99 例 HNSCC 患者中收集回顾性数据。不重新计划,对 PD 和其他危及器官(OAR)进行(重新)轮廓和剂量体积直方图(DVH)生成。根据 CTCAE v.4.03 对 SSX 进行分级,并在急性、亚急性和两个晚期进行评估。

结果

大多数患者表现为局部区域晚期疾病。在 47%的患者中,CRT 前进行了颈部清扫术。双侧腮腺的加权平均剂量为 28.6Gy,PD 为 32.0Gy。急性 SSX 表现为 0 级(35.3%)、1 级(41.4%)、2 级(21.2%)和 3 级(2.0%)。单变量逻辑回归(LR)未显示 OAR 与 SSX≥2 级之间存在关联。多变量 LR 显示,急性 SSX 与以下因素存在统计学显著相关性:PG 加权平均剂量(OR 0.84,p=0.004)、对侧 PG 平均剂量(OR 1.14,p=0.02)和对侧 PD 计划 OAR(PD PRV)平均剂量(OR 1.84,p=0.03)。

结论

多变量回归仅显示急性 SSX 与 PD PRV 剂量暴露有关。由于统计不确定性和分析的回顾性,需要进一步的研究来证实或拒绝这一假设。

相似文献

1
Effect of dose to parotid ducts on Sticky Saliva and Xerostomia in radiotherapy of head and neck squamous cell carcinoma.腮腺导管剂量对头颈部鳞状细胞癌放疗后粘性唾液和口干的影响。
Radiat Oncol. 2024 Aug 2;19(1):104. doi: 10.1186/s13014-024-02495-6.
2
Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy.唾液功能的恢复:保留对侧腮腺的调强放射治疗与双侧保留腮腺浅叶的调强放射治疗对比
Clin Oncol (R Coll Radiol). 2016 Sep;28(9):e69-e76. doi: 10.1016/j.clon.2016.02.009. Epub 2016 Mar 17.
3
Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.头颈部癌症患者接受或不接受对侧颌下腺保护的调强放疗后唾液腺剂量对唾液分泌和口干程度恢复的影响:一项纵向研究。
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1479-87. doi: 10.1016/j.ijrobp.2010.07.1990. Epub 2010 Oct 8.
4
A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.一项关于患者相关参数对头颈部鳞状细胞癌调强放疗保留腮腺能力影响的研究。
J Cancer Res Ther. 2018 Oct-Dec;14(6):1220-1224. doi: 10.4103/jcrt.JCRT_362_16.
5
Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.头颈部癌患者的调强放疗或容积调强弧形放疗:聚焦于唾液腺剂量测定。
Head Neck. 2016 Jul;38(7):1028-34. doi: 10.1002/hed.24398. Epub 2016 Feb 8.
6
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.一项针对接受调强放疗或三维放疗的头颈癌患者唾液功能保留情况的前瞻性研究:初步结果。
Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):907-16. doi: 10.1016/s0360-3016(00)01441-3.
7
Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.利用腮腺和颌下腺的 MR 和 CT 影像组学预测头颈部癌症的急性放射性口干症。
Radiat Oncol. 2019 Jul 29;14(1):131. doi: 10.1186/s13014-019-1339-4.
8
The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures.腮腺保护调强放疗对唾液成分、流率和口干测量的影响。
Oral Dis. 2017 Oct;23(7):990-1000. doi: 10.1111/odi.12686. Epub 2017 Jun 5.
9
Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?放疗后口干症。什么更重要——平均总剂量还是每个腮腺的剂量?
Strahlenther Onkol. 2013 Mar;189(3):216-22. doi: 10.1007/s00066-012-0257-2. Epub 2013 Jan 27.
10
Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.放疗后头颈部癌症患者口腔口干症状的患者自评和医生评估与口腔和唾液腺剂量分布的关系。
Acta Oncol. 2019 Oct;58(10):1366-1372. doi: 10.1080/0284186X.2019.1627413. Epub 2019 Jun 26.

引用本文的文献

1
Survival benefit added by adjuvant chemotherapy in adenoid cystic carcinoma of salivary gland.辅助化疗对唾液腺腺样囊性癌的生存获益。
Sci Rep. 2024 Oct 28;14(1):25746. doi: 10.1038/s41598-024-77296-8.

本文引用的文献

1
Prospective assessment of sparing the parotid ducts via MRI sialography for reducing patient reported xerostomia.前瞻性评估 MRI 涎管造影术保留腮腺导管以减少患者报告的口干症。
Radiother Oncol. 2022 Jul;172:42-49. doi: 10.1016/j.radonc.2022.05.001. Epub 2022 May 7.
2
Parotid Gland Stem Cell Sparing Radiation Therapy for Patients With Head and Neck Cancer: A Double-Blind Randomized Controlled Trial.头颈部癌患者腮腺干细胞保留放疗:一项双盲随机对照试验
Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):306-316. doi: 10.1016/j.ijrobp.2021.09.023. Epub 2021 Sep 24.
3
Delta-radiomics features during radiotherapy improve the prediction of late xerostomia.
放疗过程中的 Delta 放射组学特征可改善口干症晚期的预测。
Sci Rep. 2019 Aug 28;9(1):12483. doi: 10.1038/s41598-019-48184-3.
4
Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.利用腮腺和颌下腺的 MR 和 CT 影像组学预测头颈部癌症的急性放射性口干症。
Radiat Oncol. 2019 Jul 29;14(1):131. doi: 10.1186/s13014-019-1339-4.
5
NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.调强放疗治疗头颈部癌症后患者自评口干和粘性唾液的 NTCP 模型:剂量学和临床因素的作用。
Radiother Oncol. 2012 Oct;105(1):101-6. doi: 10.1016/j.radonc.2012.03.004. Epub 2012 Apr 18.
6
Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial.提高头颈部放疗治疗指数的新方法:PARSPORT 随机 III 期试验数据分析。
Radiother Oncol. 2012 Apr;103(1):82-7. doi: 10.1016/j.radonc.2012.02.006. Epub 2012 Mar 21.
7
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.腮腺保留调强放疗与常规放疗治疗头颈部肿瘤(PARSPORT):一项 3 期多中心随机对照试验。
Lancet Oncol. 2011 Feb;12(2):127-36. doi: 10.1016/S1470-2045(10)70290-4. Epub 2011 Jan 12.
8
Radiotherapy dose-volume effects on salivary gland function.放疗剂量-体积效应对唾液腺功能的影响。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S58-63. doi: 10.1016/j.ijrobp.2009.06.090.
9
Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life.保留腮腺的调强放射治疗用于头颈癌可改善与口干相关的生活质量。
Radiat Oncol. 2008 Dec 9;3:41. doi: 10.1186/1748-717X-3-41.
10
Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.放疗治疗的头颈癌患者中,迟发性治疗相关毒性对生活质量的影响。
J Clin Oncol. 2008 Aug 1;26(22):3770-6. doi: 10.1200/JCO.2007.14.6647.